We have multiple programmes in pre-clinical and clinical phases across contrast media and molecular imaging with research and development hubs located in:
• Amersham, UK
• Oslo, Norway
• Shanghai, China
• Toulouse, France
• Japan

We also partner with top academic centres in the US, Europe, and Asia.

We are committed to the efficient use of resources required for producing and delivering our imaging agents whilst minimizing our impact on the environment. We also support customers to optimize contrast media use where possible.